Cardiomyocyte-Specific Endothelin A Receptor Knockout Mice Have Normal Cardiac Function and an Unaltered Hypertrophic Response to Angiotensin II and Isoproterenol

REFERENCES

• Agah, R., P. A. Frenkel, B. A. French, L. H. Michael, P. A. Overbeek, and M. D. Schneider. 1997. Gene recombination in postmitotic cells: targeted expression of cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo. J. Clin. Investig. 100: 169–179.
   PubMed Web of Science ®Google Scholar
• Arai, H., S. Hori, I. Aramori, H. Okhuba, and S. Nakanishi. 1990. Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730–732.
   PubMed Web of Science ®Google Scholar
• Araki, K., M. Araki, J. Miyazaki, and P. Vassalli. 1995. Site-specific recombination of a transgene in fertilized eggs by transient expression of cre recombinase. Proc. Natl. Acad. Sci. USA 92: 160–164.
   PubMed Web of Science ®Google Scholar
• Battistini, B., P. D'Orleans-Juste, and P. Sirois. 1993. Endothelins: circulatory plasma levels and presence in other biologic fluids. Lab. Investig. 68: 600–628.
   PubMed Web of Science ®Google Scholar
• Beyer, M. E., G. Slesak, H. M. Hoffmeister. 1995. In vivo hemodynamic and inotropic effects of the endothelinB agonist IRL 1620. J. Cardiovasc. Physiol. 26S3: S190–S192.
   Google Scholar
• Clouthier, D. E., K. Hosoda, J. A. Richardson, S. C. Williams, H. Yanagisawa, T. Kuwaki, M. Kumada, R. E. Hammer, and M. Yanagisawa. 1998. Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice. Development 125: 813–824.
   PubMed Web of Science ®Google Scholar
• Cullen, J. P., D. Bell, E. J. Kelso, B. J. McDermott. 2001. Use of A-192621 to provide evidence for involvement of endothelin ETB receptors in endothelin-1-mediated cardiomyocyte hypertrophy. Eur. J. Pharmacol. 417: 157–168.
   PubMedGoogle Scholar
• Douglas, S. A., and E. H. Ohlstein. 1997. Signal transduction mechanisms mediating vascular actions of endothelin. J. Vasc. Res. 34: 152–164.
   PubMed Web of Science ®Google Scholar
• Fareh, J., R. M. Touyz, E. L. Schiffrin, and G. Thibault. 1996. Endothelin-1 and angiotensin II receptors in cells from rat hypertrophied heart. Circ. Res. 78: 302–311.
   PubMedGoogle Scholar
• Friddle, C. J., T. Koga, E. M. Rubin, and J. Bristow. 2000. Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc. Natl. Acad. Sci. USA 97: 6745–6750.
   PubMedGoogle Scholar
• Gray, M. O., C. S. Long, J. E. Kalinyak, H. T. Li, and J. S. Karliner. 1998. Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-B and endothelin-1 from fibroblasts. Cardiovasc. Res. 40: 352–363.
   PubMed Web of Science ®Google Scholar
• Griendling, K. K., B. Lassegue, and R. W. Alexander. 1996. Angiotensin receptors and their therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 36: 281–306.
   PubMed Web of Science ®Google Scholar
• Gu, H., J. D. Marth, P. C. Orban, H. Mossman, and K. Rajewsky. 1994. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265: 103–106.
   PubMed Web of Science ®Google Scholar
• Hamawaki, M., T. M. Coffman, A. Lashus, M. Koide, M. R. Zile, M. I. Oliverio, G. DeFreyte, G. Cooper IV, and B. A. Carabello. 1998. Pressure-overload hypertrophy is unabated in mice devoid of AT1A receptors. Am. J. Physiol. 274: H868–H873.
   PubMedGoogle Scholar
• Harada, K., I. Komuro, I. Shiojima, D. Hayashi, S. Kudoh, T. Mizuno, K. Kijima, H. Matsubara, T. Sugaya, K. Murakami, and Y. Yazaki. 1998. Pressure overload induces hypertrophy in angiotensin II type 1A receptor knockout mice. Circulation 97: 1952–1959.
   PubMedGoogle Scholar
• Herizi, A., B. Jover, N. Bouriquet, and A. Mimran. 1998. Prevention of cardiovascular and renal effects of angiotensin II by endothelin blockade. Hypertension 31: 10–14.
   PubMed Web of Science ®Google Scholar
• Ishikawa, T., M. Yanagisawa, S. Kimura, K. Goto, and T. Masaki. 1988. Positive chronotropic effects of endothelin, a novel endothelium-derived vasoconstrictor peptide. Pfluegers Arch. 413: 108–110.
   PubMed Web of Science ®Google Scholar
• Ito, H., Y. Hirata, S. Adachi, M. Tanaka, M. Tsujino, A. Koike, A. Nogami, F. Murumo, and M. Hiroe. 1993. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J. Clin. Investig. 92: 398–403.
   PubMed Web of Science ®Google Scholar
• Kasai, H., M. Takanashi, C. Takasaki, and M. Endoh. 1994. Pharmacological properties of endothelin receptor subtypes mediating positive inotropic effects in rabbit heart. Am. J. Physiol. 266: H2220–H2228.
   PubMedGoogle Scholar
• Kedzierski, R. M., T. Ohuchi, E. Isotani, Y. Y. Kisanuki, S. C. Williams, R. E. Hammer, J. A. Richardson, C. P. Reagan, G. K. Owens, K. E. Kamm, and M. Yanagisawa. Endothelin-A receptor gene knockout in smooth muscle causes hypotension and reveals an endothelin-B-mediated compensation in mice. In press.
   Google Scholar
• Kedzierski, R. M., and M. Yanagisawa. 2001. Endothelin system: the double-edged sword in health and disease. Annu. Rev. Pharmacol. Toxicol. 41: 851–876.
   PubMed Web of Science ®Google Scholar
• Kisanuki, Y. Y., R. E. Hammer, J. Miyazaki, S. C. Williams., J. A. Richardson, and M. Yanagisawa. 2001. Tie2-cre transgenic mice: a new model for endothelial cell lineage analysis in vivo. Dev. Biol. 230: 230–242.
   PubMed Web of Science ®Google Scholar
• Kurihara, Y., H. Kurihara, H. Suzuki, T. Kodama, K. Maemura, R. Nagai, H. Oda, T. Kuwaki, W. H. Cao, N. Kamada, et al. 1994. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368: 703–710.
   PubMed Web of Science ®Google Scholar
• Morimoto, T., K. Hasegawa, H. Wada, T. Kakita, and S. Kaburagi. 2001. Calcineurin-GATA4 pathway is involved in beta-adrenergic agonist-responsive endothelin-1 transcription in cardiac myocytes. J. Biol. Chem. 276: 34983–34989.
   PubMedGoogle Scholar
• Mulder, P., V. Richard, G. Derumeaux, M. Hogie, J. P. Henry, F. Lallemand, P. Compagnon, B. Mace, E. Comoy, B. Letac, and C. Thuillez. 1997. Role of endogenous endothelin in chronic heart failure: effects of long-term treatment with an endothelin antagonist on survival, haemodynamics, and cardiac remodeling. Circulation 96: 1976–1982.
   PubMed Web of Science ®Google Scholar
• Nicoletti, A., and J.-B. Michel. 1999. Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors. Cardiovasc. Res. 41: 532–543.
   PubMed Web of Science ®Google Scholar
• Saetrum Opgaard, O., S. Moller, R. de Vries, L. Edvinsson, and P. R. Saxena. 2000. Positive inotropic responses mediated by endothelin ETA and ETB receptors in human myocardial trabeculae. Clin. Sci. 99: 161–168.
   Web of Science ®Google Scholar
• Sakai, S., T. Miyauchi, M. Kobayashi, I. Yamaguchi, K. Goto, and Y. Sugishita. 1996. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 384: 353–355.
   PubMed Web of Science ®Google Scholar
• Sakai, S., T. Miyauchi, T. Sakurai, Y. Kasuya, M. Ihara, I. Yamaguchi, K. Goto, and Y. Sugishita. 1996. Endogenous endothelin-1 participates in the maintenance of cardiac function in rats with congestive heart failure. Marked increase in endothelin-1 production in the failing heart. Circulation 93: 1214–1222.
   PubMed Web of Science ®Google Scholar
• Sakurai, T., M. Yanagisawa, Y. Takuwa, H. Miyazaki, S. Kimura, K. Goto, and T. Masaki. 1990. Cloning of a cDNA encoding a non-isopeptide-selective subtype of an endothelin receptor. Nature 348: 732–735.
   PubMed Web of Science ®Google Scholar
• Soonpaa, M. H., K. K. Kim, L. Pajak, M. Franklin, and L. J. Field. 1996. Cardiomyocyte DNA synthesis and binucleation during murine development. Am. J. Physiol. 271: H2183–H2189.
   PubMed Web of Science ®Google Scholar
• Tanaka, N., N. Dalton, L. Mao, H. A. Rockman, K. L. Peterson, K. R. Gottshall, J. J. Hunter, K. R. Chien, and J. Ross, Jr. 1996. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation 94: 1109–1170.
   PubMed Web of Science ®Google Scholar
• Yamauchi-Kohno, R., T. Miyauchi, T. Hoshino, T. Kobayashi, H. Aihara, S. Sakai, H. Yabana, K. Goto, Y. Sugishita, and S. Murata. 1999. Role of endothelin in deterioration of heart failure due to cardiomyopathy in hamsters: increase in endothelin-1 production in the heart and the beneficial effects of endothelin-A receptor antagonist on survival and cardiac function. Circulation 99: 2171–2176.
   PubMedGoogle Scholar
• Yanagisawa, M., H. Kurihara, S. Kimura, Y. Tomobe, M. Kobayashi, Y. Mitsui, Y. Yazaki, K. Goto, and T. Masaki. 1988. A novel vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415.
   PubMed Web of Science ®Google Scholar
• Yorikane, R., S. Sakai, T. Miyauchi, T. Sakurai, Y. Sugishita, and K. Goto. 1993. Increased production of endothelin-1 in the hypertrophied rat heart due to pressure overload. FEBS Lett. 332: 31–34.
   PubMed Web of Science ®Google Scholar
• Zolk, O., J. Quattek, G. Sitzler, T. Schrader, G. Nickenig, P. Schnabel, K. Shimada, M. Takahashi, and M. Bohm. 1999. Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure. Circulation 99: 2118–2123.
   PubMed Web of Science ®Google Scholar